BACKGROUND: Troponin elevation in patients with stable coronary heart disease is associated with adverse outcome and prognosis. However, the mechanism is not yet clearly understood. Our objectives were to examine the prevalence and range of cardiac troponin T (cTnT) in stable patients, 6 months after acute myocardial infarction (AMI) using a new high sensitive cTnT assay and to investigate the association of minor cTnT elevation in these patients to clinical variables, NT-proBNP and cardiac MRI-findings. STUDY DESIGN AND METHODS: cTnT was measured in 98 patients 6 months after AMI with a precommercial assay by electrochemiluminescence methods (Roche Diagnostics, Mannheim, Germany). cTnT values were correlated with clinical and angiographic variables, NT-proBNP concentrations and with cardiac MRI-findings. RESULTS: Minor cTnT concentrations were detectable in 90% of the entire cohort, of whom 16% had cTnT values above the 99th percentile (>12 ng/L). These patients were also significantly older, suffered more frequently from hypertension, had a higher New York Heart Association class and received more often diuretics at follow up. Patients with cTnT elevation had a more impaired left ventricular ejection fraction (P = 0.02) but did not have an increased infarct size (P = 0.73). CONCLUSIONS: Elevated minor cTnT levels are frequently detectable in patients 6 months after AMI. Increased cTnT level were associated with clinical parameter for heart failure, impaired ejection fraction and higher NT-proBNP levels suggesting that myocardial dysfunction is a main cause for cTnT elevation in these patient group.
BACKGROUND: Troponin elevation in patients with stable coronary heart disease is associated with adverse outcome and prognosis. However, the mechanism is not yet clearly understood. Our objectives were to examine the prevalence and range of cardiac troponin T (cTnT) in stable patients, 6 months after acute myocardial infarction (AMI) using a new high sensitive cTnT assay and to investigate the association of minor cTnT elevation in these patients to clinical variables, NT-proBNP and cardiac MRI-findings. STUDY DESIGN AND METHODS: cTnT was measured in 98 patients 6 months after AMI with a precommercial assay by electrochemiluminescence methods (Roche Diagnostics, Mannheim, Germany). cTnT values were correlated with clinical and angiographic variables, NT-proBNP concentrations and with cardiac MRI-findings. RESULTS: Minor cTnT concentrations were detectable in 90% of the entire cohort, of whom 16% had cTnT values above the 99th percentile (>12 ng/L). These patients were also significantly older, suffered more frequently from hypertension, had a higher New York Heart Association class and received more often diuretics at follow up. Patients with cTnT elevation had a more impaired left ventricular ejection fraction (P = 0.02) but did not have an increased infarct size (P = 0.73). CONCLUSIONS: Elevated minor cTnT levels are frequently detectable in patients 6 months after AMI. Increased cTnT level were associated with clinical parameter for heart failure, impaired ejection fraction and higher NT-proBNP levels suggesting that myocardial dysfunction is a main cause for cTnT elevation in these patient group.
Authors: W Cheng; B Li; J Kajstura; P Li; M S Wolin; E H Sonnenblick; T H Hintze; G Olivetti; P Anversa Journal: J Clin Invest Date: 1995-11 Impact factor: 14.808
Authors: G Rioufol; G Finet; I Ginon; X André-Fouët; R Rossi; E Vialle; E Desjoyaux; G Convert; J F Huret; A Tabib Journal: Circulation Date: 2002-08-13 Impact factor: 29.690
Authors: Kai M Eggers; Bo Lagerqvist; Jonas Oldgren; Per Venge; Lars Wallentin; Bertil Lindahl Journal: Am Heart J Date: 2008-07-22 Impact factor: 4.749
Authors: Hassan Abdel-Aty; Anja Zagrosek; Jeanette Schulz-Menger; Andrew J Taylor; Daniel Messroghli; Andreas Kumar; Michael Gross; Rainer Dietz; Matthias G Friedrich Journal: Circulation Date: 2004-05-03 Impact factor: 29.690
Authors: Lutz Frankenstein; Andrew Remppis; Evangelos Giannitis; Joerdis Frankenstein; Georg Hess; Dietmar Zdunek; Andreas Doesch; Christian Zugck; Hugo A Katus Journal: Clin Res Cardiol Date: 2011-02-17 Impact factor: 5.460
Authors: Andreas Rolf; Birgit Assmus; Volker Schächinger; Johannes Rixe; Susanne Möllmann; Helge Möllmann; Stefanie Dimmeler; Andreas M Zeiher; Christian W Hamm; Thorsten Dill Journal: Clin Res Cardiol Date: 2011-06-17 Impact factor: 5.460
Authors: S Celik; E Giannitsis; K C Wollert; K Schwöbel; D Lossnitzer; T Hilbel; S Lehrke; D Zdunek; A Hess; J L Januzzi; H A Katus Journal: Clin Res Cardiol Date: 2011-07-27 Impact factor: 5.460
Authors: H C Volz; D Laohachewin; D Schellberg; A R Wienbrandt; M Nelles; C Zugck; Z Kaya; H A Katus; M Andrassy Journal: Clin Res Cardiol Date: 2012-01-10 Impact factor: 5.460